BRIP1 and ovarian cancer: This study revealed a high prevalence of a BRIP1 splice site pathogenic variant (c.1936 + 1G > A) among Somali women with ovarian cancer, with 60 % of those tested (3 out of 5) carrying this pathogenic variant.